Company news
JW (Cayman) Therapeutics Co. Ltd. news in 2021
JW (Cayman) Therapeutics Co. Ltd.'s news releases, calls and decks from 2021, newest first.
JW (Cayman) Therapeutics: Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China
September 6, 2021
Change of company secretary, authorized representative and process agent
July 30, 2021
JW (Cayman) Therapeutics: Proposals for general mandates to issue shares and repurchase shares and re-election of retiring directors and re-appointment of auditor and notice of annual general meeting
April 23, 2021
Voluntary announcement - inclusion of the shares of the company in the hong kong stock connect list under the shenzhen-hong kong stock connect
March 15, 2021